TY - JOUR
T1 - Absence of VIII AHF response to adrenalin in hemophilia A
AU - Eyster, M. Elaine
AU - Dranchak, Margaret
AU - Haverstick, Judy
AU - Rogers, John S.
PY - 1977
Y1 - 1977
N2 - Proportionate twofold or greater increases in both Factor VIII procoagulant activity (VIII AHF) and Factor VIII‐like antigen (VIII AGN) have been observed to follow the administration of adrenalin in normal individuals. Levels of factor VIII procoagulant or clot‐promoting activity (VIII AHF) and VIII AGN were measured immediately before and one hour after the subcutaneous injection of adrenalin (0.35 ml) in ten adults with hemophilia A documented by low VIII AHF levels (ranging from 0.01‐0.25 units/ml, normal VIII AGN levels, and normal VIII VWF levels as measured by the washed‐platelet ristocetin assay). Eighteen normal adults served as controls. Results were analyzed by the paired t test. It was shown that VIII AGN increased significantly, while VIII AHF did not change, in hemophiliacs after adrenalin stimulation, regardless of the base line level. This fixed rate of VIII AHF production, release, or activation may help to explain the constancy of VIII AHF levels in individual hemophiliacs and their affected family members.
AB - Proportionate twofold or greater increases in both Factor VIII procoagulant activity (VIII AHF) and Factor VIII‐like antigen (VIII AGN) have been observed to follow the administration of adrenalin in normal individuals. Levels of factor VIII procoagulant or clot‐promoting activity (VIII AHF) and VIII AGN were measured immediately before and one hour after the subcutaneous injection of adrenalin (0.35 ml) in ten adults with hemophilia A documented by low VIII AHF levels (ranging from 0.01‐0.25 units/ml, normal VIII AGN levels, and normal VIII VWF levels as measured by the washed‐platelet ristocetin assay). Eighteen normal adults served as controls. Results were analyzed by the paired t test. It was shown that VIII AGN increased significantly, while VIII AHF did not change, in hemophiliacs after adrenalin stimulation, regardless of the base line level. This fixed rate of VIII AHF production, release, or activation may help to explain the constancy of VIII AHF levels in individual hemophiliacs and their affected family members.
UR - http://www.scopus.com/inward/record.url?scp=0017621434&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0017621434&partnerID=8YFLogxK
U2 - 10.1002/ajh.2830030211
DO - 10.1002/ajh.2830030211
M3 - Article
C2 - 602937
AN - SCOPUS:0017621434
SN - 0361-8609
VL - 3
SP - 193
EP - 198
JO - American Journal of Hematology
JF - American Journal of Hematology
IS - 2
ER -